Promising Breast Cancer Treatment Averts ‘Collateral Damage’ to Healthy Cells

Published August 4, 2012

Promising Breast Cancer Treatment Averts ‘Collateral Damage’ to Healthy Cells – Doctors meeting this week at a major conference in Chicago believe they are on track to create a drug that would specifically target cancer cells, while largely leaving healthy cells undamaged. Gwen Ifill and Dr. Michael Link of the American Society of Clinical Oncology discuss the findings.

Teens Who Smoke Reveal Early Signs of addiction: Study

Filed under: drug treatment news articles

This suggests, according to the study by UCSF's Mark Rubinstein, MD, that the threshold for nicotine addiction in teenagers is perhaps much lower than the common notion. "Most smoking cessation programs require that you smoke at least ten cigarettes …
Read more on Counsel & Heal

Medigene's drug VeregenR Receives Marketing Authorization in Israel …

Filed under: drug treatment news articles

Medigene AG (MDG, Frankfurt, Prime Standard) announced today that Veregen R for the treatment of genital warts has obtained marketing authorization in Israel, Denmark and Slovakia. Market launch of Veregen R in Denmark, Norway and Sweden by Medigene's …
Read more on Reuters

New Published Data Demonstrate Endocyte's Targeted Small Molecule Drug …

Filed under: drug treatment news articles

3, 2012 (GLOBE NEWSWIRE) — Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that Endocyte's approach of …
Read more on NASDAQ